BPC-157 is a peptide derived from a protective protein found in the human stomach, known as the Body Protection Compound. It has been extensively studied in animal and cell models for its potential to accelerate healing of muscles, tendons, ligaments, nerves, and the gastrointestinal tract. Research suggests BPC-157 supports tissue repair by promoting angiogenesis (new blood vessel growth), enhancing collagen production, and modulating inflammatory and nitric oxide pathways that influence cell regeneration. Studies also suggest BPC-157 protects against gut injury, improves joint recovery, and reduces inflammation.
BPC-157
Dosing Guidance
Standard daily doses range from 300-500 mcg, often administered 1-2 times per day over a period of 4-8 weeks.
Higher dosing protocols (500-750 mcg, 2-3x daily) are considered more advanced.
Standard Dosing Protocol:
300-500 mcg, 1-2x daily, 4-8 weeks
For a standard daily regimen, reconstitute with 3 mL of bacteriostatic water (total 10 mg). That yields ~3,333 mcg per mL. Note that 300 mcg is ~9 units, which is slightly below 10 units. If precision is a concern, consider using smaller insulin syringes.
1. Draw 3.0 ml of bacteriostatic water into a sterile syringe.
2. Inject the water slowly along the vial wall to reduce foam.
3. Gently swirl/roll the vial, avoid vigorous shaking.
4. To store, refrigerate the reconstituted solution at 2–8 °C, protected from light.
Advanced Dosing Protocol:
300-500 mcg, 1-2x daily, 4-8 weeks
Recommended for those referencing higher BPC-157 dosing schedules. Reconstitute with 2 mL to reach ~5,000 mcg/mL. Each injection volume remains within a practical range on a 100-unit insulin syringe.
1. Draw 2mL of bacteriostatic water into a sterile syringe.
2. Inject the water slowly along the vial wall to reduce foam.
3. Gently swirl/roll the vial, avoid vigorous shaking.
4. To store, refrigerate the reconstituted solution at 2–8 °C, protected from light.